Emanueli C - Search Results

1

Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart disease.

Avolio E, Rodriguez-Arabaolaza I, Spencer HL, Riu F, Mangialardi G, Slater SC, Rowlinson J, Alvino VV, Idowu OO, Soyombo S, Oikawa A, Swim MM, Kong CH, Cheng H, Jia H, Ghorbel MT, Hancox JC, Orchard CH, Angelini G, Emanueli C, Caputo M, Madeddu P. Avolio E, et al. Among authors: emanueli c. J Am Heart Assoc. 2015 Jun 16;4(6):e002043. doi: 10.1161/JAHA.115.002043. J Am Heart Assoc. 2015. PMID: 26080813 Free PMC article.

2

Renin-angiotensin and kallikrein-kinin systems coordinately modulate angiogenesis.

Emanueli C, Madeddu P. Emanueli C, et al. Hypertension. 2002 Jun;39(6):e29. doi: 10.1161/01.hyp.0000018956.63639.7f. Hypertension. 2002. PMID: 12052854 No abstract available.

3

Paracrine control of vascularization and neurogenesis by neurotrophins.

Emanueli C, Schratzberger P, Kirchmair R, Madeddu P. Emanueli C, et al. Br J Pharmacol. 2003 Oct;140(4):614-9. doi: 10.1038/sj.bjp.0705458. Epub 2003 Aug 26. Br J Pharmacol. 2003. PMID: 12970083 Free PMC article. Review.

4

Genetically engineered stem cell therapy for tissue regeneration.

Alessandri G, Emanueli C, Madeddu P. Alessandri G, et al. Among authors: emanueli c. Ann N Y Acad Sci. 2004 May;1015:271-84. doi: 10.1196/annals.1302.023. Ann N Y Acad Sci. 2004. PMID: 15201167 Review.

5

Changing the logic of therapeutic angiogenesis for ischemic disease.

Emanueli C, Madeddu P. Emanueli C, et al. Trends Mol Med. 2005 May;11(5):207-16. doi: 10.1016/j.molmed.2005.03.007. Trends Mol Med. 2005. PMID: 15882608 Review.

6

In search of the best candidate for regeneration of ischemic tissues: are embryonic/fetal stem cells more advantageous than adult counterparts?

Emanueli C, Lako M, Stojkovic M, Madeddu P. Emanueli C, et al. Thromb Haemost. 2005 Oct;94(4):738-49. doi: 10.1160/TH05-04-0233. Thromb Haemost. 2005. PMID: 16270625 Review.

7

Therapeutic angiogenesis: translating experimental concepts to medically relevant goals.

Emanueli C, Madeddu P. Emanueli C, et al. Vascul Pharmacol. 2006 Nov;45(5):334-9. doi: 10.1016/j.vph.2006.08.012. Epub 2006 Aug 23. Vascul Pharmacol. 2006. PMID: 17008132 Review.

8

Type-2 diabetic Lepr(db/db) mice show a defective microvascular phenotype under basal conditions and an impaired response to angiogenesis gene therapy in the setting of limb ischemia.

Emanueli C, Caporali A, Krankel N, Cristofaro B, Van Linthout S, Madeddu P. Emanueli C, et al. Front Biosci. 2007 Jan 1;12:2003-12. doi: 10.2741/2205. Front Biosci. 2007. PMID: 17127438

9

Switching on reparative angiogenesis: essential role of the vascular erythropoietin receptor.

Madeddu P, Emanueli C. Madeddu P, et al. Among authors: emanueli c. Circ Res. 2007 Mar 16;100(5):599-601. doi: 10.1161/01.RES.0000261610.11754.b1. Circ Res. 2007. PMID: 17363704 Free PMC article. Review. No abstract available.

10

Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling.

Madeddu P, Emanueli C, El-Dahr S. Madeddu P, et al. Among authors: emanueli c. Nat Clin Pract Nephrol. 2007 Apr;3(4):208-21. doi: 10.1038/ncpneph0444. Nat Clin Pract Nephrol. 2007. PMID: 17389890 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters